Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 20, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 5,570 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on June 19, 2006, and was advised to the Company on June 20, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in the shares held in the trust similarly to other employees.
Key Facts for Investor Verification
- Transaction Date: June 19, 2006.
- Shares Transferred: 5,570 Ordinary Shares.
- Source: GlaxoSmithKline Employee Trust (GSK Trust).
- Beneficiaries: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Directors Involved: Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop hold interests in the trust shares.